The implantation of inflatable penile prostheses for the treatment of erectile dysfunction continues to be widely practiced in the United States and internationally. As third-line therapy for erectile dysfunction, the numbers of implants continue to rise as the population of men treated for erectile dysfunction increases. Complications of penile prosthesis implantation continued to decline as mechanical malfunctions have decreased as a result of re-engineering inflatable penile prostheses. Inflatable penile prostheses from both available vendors continue to be reliable, effective methods for restoring erectile function with high satisfaction rates. The most troublesome complication of these prostheses, however, is not mechanical but rather that of prosthesis infection. Prosthesis infections may result in further surgery, loss of penile tissue, and even the inability to replace penile prosthesis. While standard sterile technique perioperative antibiotics and careful surgical procedures continue to be the cornerstone of penile prosthesis infection avoidance, newer designs of penile prostheses for antibiotic coating have resulted in an improvement in the prevalence and incidents of penile prosthesis infection. For those patients in whom penile prostheses become infected despite adequate prophylaxis, newer techniques of salvage have demonstrated increasing success. Once and still the most dreaded complication of penile prosthesis implantation, prothesis infections can now be avoided by perioperative preparation and antibiotics as well as antibioticcoated penile prostheses. Treatment of penile prosthesis infections once associated with severe loss of function can often be successful with modern salvage techniques. Implanting urologists must be familiar prophylaxis, avoidance, and treatment of penile prosthesis infections.
Introduction
Prosthetic implant-associated infections have been documented in all implants of artificial materials. These infections comprise the most disastrous complications of surgical implantation of prosthetic devices. The development of implantable genitourinary prostheses began with simple testicular implants and has progressed to the current variety of penile prostheses, artificial urinary sphincters, stents, and possible future implantable devices such as artificial bladders and ureters. It has been estimated that more than 15 000 penile prosthesis operations are carried out in the United States annually. While mechanical malfunction is the most frequent complication of complex prosthetic devices such as penile implants, infection continues to be the most dreaded complication. Prosthesis-associated infections often result in removal of the device, severe disability, loss of function, loss of tissue, and difficulty with subsequent implantation. Genital gangrene with extensive tissue loss is the most severe and dreaded manifestation of this difficult complication. 1 The cost of penile prosthesis infection prevention is minimal while the cost of treating an infected penile prosthesis is considerable. It has been estimated that the cost of treating infected penile prostheses exceeds the cost of the original prosthetic implant by more than six-fold. 2 As the number and frequency of these procedures increase, the absolute numbers of infections associated with prosthetic devices will also increase. Indeed, the prevalence of prosthesis-associated infections has varied little over the three decades of their widespread availability (Table 1) .
While the exact time of bacterial exposure to implanted prostheses remains controversial, most often these bacteria colonize prostheses at the time of implantation. 4 Bacteria may also come in contact with prosthetic materials through hematogenous or lymphatic spread. 5 Carson and Robertson 5 reported hematogenous penile prosthesis infections occurring with potential responsibility for late prosthesis infections. Fishman et al, 6 however, considered hematogenous infection less common and believed bacterial biofilm may allow infection to be quiescent for many years before clinical demonstration. The experience of Fishman et al 6 demonstrated that 56% of prosthesis infection occurred within 7 months of implantation, 36% between 7 and 12 months, and only 2.6% after 5 y.
Pathogenic organisms
Staphyloccus species, especially Staphylococcus epidermidis are the most common organisms identified in penile prosthesis infection and have been isolated from 35 to 56% of infected penile prosthesis patients. Licht et al 7 found S. epidermidis cultured from implants removed from patients for mechanical malfunction without evidence for infection. In their series, 40% of penile prostheses and 36% of artificial urinary sphincters cultured low colony counts of S. epidermidis. Only 9% subsequently had infections, all of which had higher colony counts. 8 Henry et al 9 reported a multicenter study of culture of all portions of prostheses removed for mechanical failure. In this carefully done study, 70% of removed prostheses were colonized and the pathogens were usually S. epidermidis or S. lugdunensis. S. epidermidis and other staphylococcal species have an enhanced ability to produce glycocalyx biofilm that potentiates their infectious activity and capacity. 4 Gram-negative enteric bacteria may also be pathogens in prosthetic infections. Thomalla et al 8 studied 23 patients with penile prostheses removed for infection. In addition to the most common staphylococcal pathogens, Gram-negative organisms included Proteus mirabilis in six patients, P. aeruginosa in four patients, Escherichia coli in two patients and Serratia marcescens in two patients. 8 Montague et al 2 found that Gram-negative organisms accounted for 20% of penile prosthesis infections in his series. Infections caused by these Gram-negative organisms were more likely to occur at an earlier time with an average time to infection of less than 1 month after implantation compared with 5.75 months in those patients infected with staphylococcal organisms. 2 Occasionally, in severe infections, Gram-negative organisms can combine with anaerobic organisms such as Bacterioides to produce gangrene of the penis. Other organisms such as fungal and mycobacteria organisms can produce infections in prostheses. Peppas et al 10 reported a case of bilateral fungal corporeal abscess caused by Candida albicans that was probably related to a remote fungal skin infection. Fishman reported Candida albicans as a pathogen in as many as 5% of infections; Nelson and Gregory 11 presented two cases of penile prosthesis infection caused by Neisseria gonorrhea. 6 
Risk factors for prosthesis infection
Risk factors that increase penile prosthesis infection incidence include both patient and facility factors. Prolonged hospitalization is a risk factor for skin flora changes producing more virulent pathogens at the time of surgery. Thus, same day admissions are helpful for decreasing wound infections. Other host factors may increase infection risks for some patients. The most controversial risk factor is that of diabetes mellitus. Fallon and Ghanem 12 reported that diabetes mellitus increased infection risks in penile prosthesis by more than three-fold compared with other causes of erectile dysfunction. 13 Jarow reported no increase in prosthesis infection risks among diabetic patients requiring penile prosthesis implantation or reconstructive procedures. Bishop et al 14 suggests that alterations in defense mechanisms typical of diabetic patients will increase the incidence of penile prosthesis infection in these men. The authors conclude that infections can be predicted and quantified using glycosylated hemoglobin as a marker for diabetic infection potential. Wilson et al 15 in review of 389 men undergoing penile prostheses, including 114 diabetics. Glycosylated hemoglobin was measured and had no predictive value for penile prosthesis infection. While there were more infections among diabetics (8.7%) compared with nondiabetics (4.0%), infections could not be predicted based on fasting blood sugars, insulin-dependence or glycosylated hemoglobin A1C. There were no differences in median or mean hemoglobin A1C levels in infected or noninfected patients in diabetics and nondiabetics.
Multiple 17 have documented an increased infection risk when using additional foreign bodies such as Gor-tex or dacron in association with penile prosthesis implantation. Patients with paraplegia, spinal cord injury, or other neurologic deficits also appear to have increased risks for penile prosthesis infections. An increased incidence of prosthesis associated infections from 8 to 33% has been reported for patients with spinal cord injury. 18 Wilson and Delk 19 report a 9% incidence of infection in patients with spinal cord injury compared with an index rate of 1% in 1337 consecutive penile prosthesis implantations. Patients with significant immune compromise, however, are at significant increased risk for infectious complication. 20, 21 This includes medical as well as pharmacologic immune compromise. Sidi et al, 21 however, followed 13 immune compromised organ transplantation patients with penile prosthesis implantation and found no infectious complications in this group.
Patients who have immune compromise, severe, poorly controlled diabetes, spinal cord injury, or have had multiple surgical procedures increase their risk of post-prosthesis implantation infection, this risk continues to be statistically small and clearly does not contraindicate penile prosthesis implantation in these patients. 22 These special risk factors strongly support increased attention to the principles of infection prevention.
Infection prevention
Prevention of perioperative surgical infections is the most important aspect of penile prosthesis implantation and management. Short preoperative stays have been documented to maintain low virulence, and high antibiotic susceptibility of skin flora. Skin flora changes with hospitalization, which occur within 24 h of hospital admission. During this time, normal skin flora consisting of susceptible Grampositive organisms are replaced by nosocomial Gram-negative, anaerobic or resistant Gram-positive organisms, all of which may be resistant to standard courses of perioperative preventative antibiotics.
Preoperative preparation must include elimination of all remote infections that can produce contamination or hematogenous spread of infection following implantation. It is important to document sterile urine and eliminate skin or other remote infections prior to surgery.
The use of prophylactic perioperative antibiotics for implantation of all prosthetic devices has become established despite some continued controversy. 23 Because of the cost of treatment of prosthetic infections is significant, perioperative antibiotics must be considered as cost effective. Most common pathogenic bacteria most likely to produce infections must be targeted when choosing appropriate perioperative prophylactic antibiotics. In the urologic patient who is undergoing prosthetic surgery, wounds are contaminated with Grampositive organisms such as S. aureus or S. epidermidis. As these organisms are indigenous to patients' skin and rarely of hospital origin, they are sensitive to most antibiotic agents. Gram-negative organisms from the patients' fecal flora are also common infectious agents in urologic patients. Selection of appropriate prophylactic antibiotics must, therefore, be aimed at the most commonly involved organisms. 23 Cephalosporins and flouroquinolones have been shown to be effective in most perioperative settings. In addition to skin wound levels, many antibiotics penetrate the corpora cavernosa well. Schwartz et al 24 investigated antibiotic tissue levels in the corpus cavernosa of patients undergoing penile prosthesis and found that oral flouroquinolone prophylaxis was as effective in obtaining high tissue levels in the corpus cavernosum as a gentamicin cefazolin combination. Thus, outpatient, oral administration of medication is possible with reduced cost.
Perioperative antibiotics are effective only if administration is begun in the immediate preoperative time. In vitro studies have demonstrated that a substantial reduction in the incidence of wound infection occurs when antibiotic concentrations in the tissue are present at the time of incision. Antibiotic agents must, therefore, be administered 1-2 h prior to surgery since those agents begun intraoperatively or postoperatively are less likely to be effective in preventing wound infection. 25 Elimination of preoperative antibiotics and a shortened interval between perioperative antibiotic administration and surgical procedures has the added advantage of decreasing the emergence of multiple drug-resistant bacteria. 25 Antibiotics should be discontinued after the threat of bacterial colonization has passed, usually within 36 h of surgery.
The operating room environment is a critical factor in prevention of prosthesis infection. Limiting operating room traffic, adequate sterile technique, minimal tissue trauma, short operating time and effective wound closure are well-known variables in the risk of perioperative infections. Patient shaving and hair removal should be performed in the operating room with minimal trauma and not before surgery. Effective skin disinfectant preparation is also critical in decreasing perioperative infections.
It has been suggested that hematogenous infections can produce late prosthesis infections in both orthopedic and urologic prostheses. 5 Clearly, significant hematogenous bacteremia can produce remote infections and colonize prostheses, the issue of antibiotic prophylaxis for minor surgical procedures and dental procedures remains controversial. Carson and Robertson 5 report a series of late infections from significant remote entry sites including active Crohn's disease, skin ulcers, and dental abscesses. Routine prophylaxis prior to dental procedures, however, does not appear to be cost effective. Jacobson et al created a decision analysis model for antibiotic prophylaxis in dental patients with joint prostheses. 26 Their analysis demonstrated that the risk of a late prosthetic joint infection from a dental visit was 29.3 cases per 10 6 dental visits. The risk of death from oral penicillin administration in their model was greater than that of a late prosthetic joint infection by 2.31-1.93. The cost of this prophylaxis was approximately 480 000 dollars to prevent one case of late prosthetic joint infection. Their conclusion was that predental antibiotic prophylaxis for patients with prosthetic joints was expensive, but not cost effective. In highly selected patients, however, especially those with immune compromise or dental abscesses, prophylactic antibiotic coverage may be appropriate.
Other risk factors for prosthetic infections have been largely discounted. High volume implantation centers may have lower infection risks than the occasional implanter, but no current data are available to confirm this opinion. Surgical approach does not appear to impact infection. Carson et al 27 reviewed more than 700 patients with primary penile implants and demonstrated no difference in infection with scrotal or infrapubic surgical approach.
Early efforts to reduce prosthesis-related infections, beyond perioperative administration of antibiotics, focused on coating catheters with antibiotics. Because S. aureus and S. epidermidis are indigenous to patients' abdominal skin and are rarely of hospital origin, they are sensitive to a variety of antimicrobial agents. In 1995, Raad et al 28 reported that in in vitro studies catheters coated with a combination of rifampin and minocycline provided significantly better inhibitory activities against S. epidermidis, S. aureus, and Enterococcus faecalis than catheters coated with vancomycin. The rifampin-minocycline combination proved superior to either drug alone, as well as other rifampincontaining combinations, such as rifampin plus vancomycin, clindamycin, or novobiocin. Raad et al 28 found that the rifampin-minocycline combination also displayed broad-spectrum inhibitory activity against Gram-negative bacteria and yeast cells. Raad et al 29 suggested that an advantage of the combination of minocycline and rifampin is that they are not used as primary agents in the treatment of systemic infections.
Additional in vitro and in vivo studies demonstrated the superior inhibitory effects of rifampinminocycline-coated catheters against Gram-positive bacteria, Gram-negative bacillary organisms and Candida albicans. 29 In subsequent clinical studies with central venous catheters, Raad et al 30 found that rifampin-minocycline-coated catheters significantly reduced the risk for catheter-related colonization and bloodstream infections. Bacterial colonization occurred with 26% of uncoated catheters compared with 8% of catheters coated with minocycline and rifampin (Po0.01). Raad further observed that the antibioticcoated catheters were not associated with adverse effects or the emergence of antimicrobial resistance.
Darouiche et al 31 observed similar results with Foley catheters in 1999. Rifampin-minocyclinecoated catheters reduced bacteriuria at 7 days (39.7% uncoated vs 15.2% coated) and at 14 days (83.5 vs 58.5%). Gram-positive bacteriuria was reduced from 38.2% with untreated catheters to 7.1% with treated catheters.
Li et al 32 found that coating silicone strips with a combination of rifampin and minocycline can reduce the incidence of graft colonization in contaminated wounds in rats even in the absence of systemic antibiotics.
Subsequent to investigations that identified the efficacy of coating prostheses with a combination of rifampin and minocycline to inhibit bacterial growth, AMS (American Medical Systems, Minnetonka, MN, USA) developed a new penile prosthesis that received FDA approval in May 2001. In the InhibiZone s prosthesis, tissue-contacting surfaces are impregnated with quantifiable doses of rifampin and minocycline that elute into the area surrounding the prosthesis postoperatively.
In addition to the demonstrated efficacy of the rifampin-minocycline combination in reducing bacterial growth, both drugs have an elution profile consistent with the objective of reducing immediate postoperative bacterial colonization of the prosthesis. Both drugs elute initially at high rates, with a significant drop-off in rifampin after day 1 and minocycline by day 7.
The pattern of infection reduction identified in Table 3 is consistent with the in vitro elution profile of rifampin and minocycline from the silicone surface of (Figure 1 ) InhibiZone s -impregnated IPPs. 33 The effect of this elution is to provide antibiotic activity both on the surface of the prosthesis components and in an area surrounding the prosthesis. The inhibitory effect of the InhibiZone s treatment is greatest for S. epidermidis and S. aureus (Table 2 ). 33 InhibiZone s prostheses, in even the largest size configurations, contain concentrations of rifampin and minocycline which are less than labeled doses (oral/i.v.) for active infection. The doses are not expected to produce measurable system blood that is levels of either drug. 34 Penile prosthesis infection CC Carson
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The recommended steps for intraoperative placement of an InhibiZone s device vs a non-InhibiZone device do not change. InhibiZone-impregnated components should not be soaked in saline or other solutions prior to implantation for a prolonged period. The prosthesis may be rinsed briefly or dipped in sterile solution immediately prior to implant. Prophylactic antibiotic protocols should be maintained as determined by the physician or institution.
Consistent with in vitro and animal studies, this retrospective review of patient records reveals that the combination of rifampin and minocycline impregnated into IPP components successfully reduces prosthesis-associated infections. Table 3 reports the data for first implants comparing Inhibizone s and non-Inhibizone implants. At all time periods reported, there was a statistically significant reduction in prosthesis-associated infections. 34 Mentor Corporation (Santa Barbara, CA, USA) has also developed a method to reduce penile prosthesis infections. The coating called Resist s is a hydrophilic coating applied to their new Titan s implants to reduce postoperative infection. This coating is intensely hydrophilic and its increased lubriciousness has been shown to decrease bacterial adherence in vitro. 35 Further, this coating absorbs antibiotics that can elute into surrounding tissues over 24-72 h to further decrease infection. While a large multicenter study is now ongoing to demonstrate clinical improvements in infection, in vitro studies have documented the infection fighting nature of this system. 36 
Prosthesis infection
Penile prosthesis infections can be divided into clinically apparent and subclinical penile prosthesis infections. Clinically apparent penile prostheses can be diagnosed from symptoms such as new onset of penile pain, erythema, and induration overlying a prosthesis part, fever, drainage, and ultimately device extrusion. While most of these infections occur in the early perioperative period, late device infections have been documented. 5 Most infections within the first 24 months follow-up, however, are probably infections caused by bacterial colonization at the time of surgery with symptoms and signs beginning later. These infections are most often associated with S. epidermidis infections on culture. Bacteria can, however, be cultured from asymptomatic penile prostheses and artificial urinary sphincters without evidence for infection. Licht et al 7 report low colony counts of S. epidermidis Figure 1 Lifetable analysis: freedom from revisions due to infection. The reduction in infection rates was greatest in the first 60 days, but was maintained beyond 80 days (Figure 1 ).
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from as many as 40% of uninfected penile prostheses and 36% of artificial urinary sphincters cultured at the time of revision for mechanical malfunction. When following these low colony count devices, less than 10%, all with high colony counts, eventually went on to penile prosthesis infection. Subclinical prosthetic infections occur more frequently. 37 These infections which most often manifest by chronic prosthesis-associated pain, are difficult to diagnose and even more challenging to treat. Device pain or migration strongly suggests that subclinical infection is present, requiring antibiotic therapy and frequently prosthesis removal and substitution. Parsons et al 37 have documented pain resolution by prosthesis removal with antibiotic irrigation and substitution of a new prosthetic device in a group of patients with prolonged isolated pain. They have been 90% successful in treating these prostheses with an exchange protocol including systemic antibiotics for 24-48 h using vancomycin to target S. epidermidis. The suspected infected prosthesis is then removed and a combination of vancomycin and protamine was used for antibiotic irrigation prior to reimplantation of a new prosthesis. Patients are maintained on vancomycin and parental antibiotics for 1 week. These authors also recommend initial trial of oral antibiotic therapy using long-term antibiotics. Following initiation of antibiotics, pain suppression should suggest continuing antibiotics for 10-12 weeks. If pain fails to resolve or rapidly returns after antibiotics, however, surgical intervention is appropriate. Parsons recommends ciprofloxacin 500 mg twice daily for 10-12 weeks with approximately a 60% success rate. Cephalosporins are also useful with cephalexin or cephradine 500 mg 4 Â daily for 10-12 weeks with success rates of 25-30%. Similar trials with orthopedic prostheses have been successful using combinations of agents including rifampin. 37 Drancourt et al 38 reviewed two antibiotic combinations for treatment of staphylococcus infections of orthopedic implants. They found that the optimal treatment combination was ofloxacin and rifampicin. They used rifampicin 900 mg daily with 600 mg of ofloxacin for 6 months. An alternative to oral rifampicin and ofloxacin was as combination of oral rifampicin with intravenous fusidic acid 1.5 g daily. (The overall success rate for antibiotic treatment was 50% in this group.)
The findings of Licht et al make it unlikely that intraoperative Gram stain with suspected penile prosthesis infection will be accurate. 5 Chimento et al 39 have reviewed Gram stain detection of infection of joint prostheses and demonstrated a 0% sensitivity for detecting infection.
If a grossly infected penile prosthesis is encountered, surgical intervention along with antibiotics is of critical importance. Salvage surgery or prosthesis removal with subsequent reimplantation is current alternatives for surgical intervention. In patients with prosthesis infections that do not include significant necrosis, diabetics with significant purulence, rapidly developing infections or significant cylinder erosion, salvage procedures can be successfully performed. It is important to carefully choose patients and to carry out rigorous surgical technique. Initially, perioperative antibiotics are administered and all portions of the penile prosthesis as well as any additional foreign bodies are removed and wound cultures are obtained. Irrigation is then carried out of all areas where the penile prosthesis resided. This is best performed using a red rubber catheter to direct irrigation fluid into all pockets in a stepwise fashion. Mulcahy and co-workers recommend a sequence of irrigating solutions including kanamycin (80 mg/l) and bacitracin (1 g/l) in normal saline followed by half-strength hydrogen peroxide, half-strength povidone/iodine solution, 5 l of pressurized normal saline containing vancomycin (1 g) and gentamicin (80 mg), half-strength povidone/ iodine, half-strength hydrogen peroxide, and finally another kanamycin/bacitracin solution 40 (Table 4) . Following irrigation, gloves, instruments, and drapes are changed and a new sterile prosthesis is inserted. Patients are treated perioperatively with antibiotics including ciprofloxacin 500 mg twice daily for 4 weeks. Antibiotics can be modified based on culture and sensitivity results. Brant et al report successful salvage in 10 of 11 (91%) patients with a 21.3 month mean follow-up. Nine of 12 patients' principle pathogen was S. epidermidis.
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In those patients with more severe infection including patients with prosthesis extrusion, gross purulence, immune compromise, and severe diabetes, a more conservative method for infected prosthesis treatment may be necessary. Removal of all foreign body and penile prosthesis components is essential with treatment of areas and pockets in a manner similar to abscess drainage including suction drains placed intracorporeally, intrascrotally in the area previously occupied by the prosthetic reservoir. 39 Suction drains are maintained with instillation of antibiotic solution every 8 h postoperatively. These drains exit suprapubically or penoscrotally and the wound is left open to heal by secondary intention with antibiotic soaked dressings. Each drain is sewn to the skin with nonabsorbable suture and thorough antibiotic irrigation of the entire wound is carried out during the prosthesis removal. Culture and sensitivities of any purulent material are evaluated from each area of prosthesis removal.
Controversy continues regarding the treatment of mild erosion and colonization. Furlow and Goldwasser 40 advocate a 'salvage approach' to these eroded prostheses in selected cases. They treated 32 patients with single component infections or erosions by replacing the eroded component with vigorous irrigation and replacement in an area not previously operated. Salvage procedures were successful in seven of nine of their patients treated without prosthesis removal. Other investigators have reported similar results. 2, 39 As the prostheses are multicomponent, the risk of other areas of biofilm containing bacteria is significant. Removal of all parts of the prosthesis with a new device implanted in a safer more conservative course. 41 In patients with severe infections and potential genitourinary gangrene, rapid prosthesis removal is imperative. 42, 43 Thorough irrigation, broad-spectrum antibiotics to include coverage for anaerobic bacteria such as Bacteroides fragilis and treatment similar to that for Fournier's gangrene may result in improved postoperative results. The addition of hyperbaric oxygen treatment may salvage some tissue in these patients. 44 Despite aggressive early intervention, however, significant tissue loss and disability can be expected and the outcome of these infections rarely results in a salvageable penis for later prosthesis implantation.
45,46
Conclusion
Infections of prosthetic devices are expected complications even under ideal circumstances. The importance of adequate prevention through preparation and perioperative antibiotics are well known. Newer antibiotic-coated devices appear to further reduce the rates of infection in original and replacement devices. Replacement procedures should be considered potentially contaminated and treated with a modified salvage procedure with irrigation and prosthesis change. Rapid identification and treatment of infected devices may lead to a better post infection outcome with recent salvage techniques.
